Z-1823-2026 Class II Ongoing
FDA device recall Z-1823-2026 was initiated by Gentuity, LLC on Mar 23, 2026 and is designated Class II. Reason for recall: The potential for repeated frames during HF-OCT pullback when using the Gentuity HF-OCT Console (software version 21.11 to 23.3.13) with the Vis-Rx and Vis-Rx Prime catheters. This correction is… The recall status is ongoing. Affected quantity: 184 units (28 US, 156 OUS).
Recall details
- Product Type
- Devices
- Report Date
- Apr 22, 2026
- Initiation Date
- Mar 23, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 184 units (28 US, 156 OUS)
Product description
Reason for recall
Distribution pattern
Domestic - US Nationwide distribution in the states of CA, FL, GA, IL, MA, MN, NJ, NY, OH, PA, TX; International: United Arab Emirates, Belgium, Switzerland, Cyprus, Denmark, Spain, Finland, France, Greece, Italy, Japan, Kuwait, Latvia, Poland, Saudi Arabia, Slovakia;
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1823-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026